Seth Klarman - Baupost Group
Holding/activity history for Idenix Pharmaceuticals Inc (IDIX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2014 Q3 | 0 | 0.00 | Sell 100.00% | 23.03 | SEC | ||
| 2014 Q2 | 53,331,109 | 23.03 | $23.81 | $1,269,560,000 | SEC | ||
| 2014 Q1 | 53,331,109 | 8.72 | Add 44.49% | 2.68 | $5.68 | $302,844,000 | SEC |
| 2013 Q4 | 36,910,868 | 7.93 | Add 24.42% | 1.56 | $5.98 | $220,727,000 | SEC |
| 2013 Q3 | 29,665,693 | 5.71 | Add 10.83% | 0.56 | $5.19 | $153,965,000 | SEC |
| 2013 Q2 | 26,767,000 | 2.97 | Add 2.78% | 0.08 | $3.61 | $96,629,000 | SEC |
| 2013 Q1 | 26,042,000 | 3.43 | Add 25.78% | 0.70 | $3.54 | $92,189,000 | SEC |
| 2012 Q4 | 20,704,700 | 3.72 | Add 72.54% | 1.56 | $4.85 | $100,418,000 | SEC |
| 2012 Q3 | 12,000,000 | 1.91 | Add 20.00% | 0.32 | $4.56 | $54,720,000 | SEC |
| 2012 Q2 | 10,000,000 | 3.00 | Add 21.23% | 0.53 | $10.28 | $102,800,000 | SEC |
| 2012 Q1 | 8,249,000 | 3.12 | Add 45.61% | 0.98 | $9.79 | $80,758,000 | SEC |
| 2011 Q4 | 5,665,000 | 1.45 | Add 126.60% | 0.81 | $7.45 | $42,176,000 | SEC |
| 2011 Q3 | 2,500,000 | 0.47 | Add 99.09% | 0.23 | $4.99 | $12,475,000 | SEC |
| 2011 Q2 | 1,255,700 | 0.31 | Buy | 0.31 | $5.00 | $6,279,000 | SEC |